Related Experiment Videos
High-resolution global profiling of genomic alterations with long oligonucleotide microarray.
Cameron Brennan1, Yunyu Zhang, Christopher Leo
1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
Cancer Research
|July 17, 2004
Summary
This study introduces a high-resolution microarray platform for genome-wide profiling of tumors. It enables sensitive detection of copy number variations in cancer genomes, aiding oncogene and tumor suppressor gene discovery.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Cancer arises from genetic alterations, with copy number variations (CNVs) being key features.
- Recurrent CNVs in cancer genomes are crucial for identifying oncogenes and tumor suppressor genes.
Purpose of the Study:
- To present a novel oligonucleotide microarray platform for high-resolution, genome-wide array-comparative genomic hybridization (aCGH) profiling.
- To detail the assay conditions and bioinformatic tools necessary for analyzing human and mouse tumor genomes.
Main Methods:
- Utilized a commercially available 60-mer oligonucleotide microarray platform.
- Developed specific assay conditions and bioinformatic tools for aCGH analysis.
- Applied the platform to profile human and mouse tumor genomes.
Main Results:
- Demonstrated the platform's sensitivity in detecting single-copy gene dosage differences in complex genomic DNA.
- Achieved high-resolution genome-wide profiling of tumors.
- Validated the utility of the platform for cancer genome analysis.
Conclusions:
- The described microarray platform offers a sensitive and high-resolution method for genome-wide DNA analysis.
- This approach facilitates the global and detailed examination of normal and diseased genomes.
- The platform and associated tools empower researchers to accelerate the discovery of cancer-related genes.